Blood Pressure, Cholesterol Before Age 55 Years Impact Risk for Heart Disease
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 20, 2023 -- Genetically predicted systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) increase the risk for coronary heart disease (CHD), independent of age, according to a study published online Dec. 20 in PLOS ONE.
Nelson Wang, M.D., Ph.D., from the University of New South Wales in Sydney, and colleagues investigated whether genetically mediated SBP/LDL-C is associated with the risk for CHD. The analysis included data from U.K. Biobank participants (136,648 for LDL-C; 135,431 for SBP; and 24,052 for CHD).
The researchers observed a consistent association between exposure to higher LDL-C and SBP, with increased odds of incident CHD in individuals aged 55 years and younger, 60 years years and younger, and 65 years and younger. Exposure to elevated LDL-C/SBP early in life (age 55 years or younger) was associated with a higher risk for CHD independent of later-life levels (age older than 55 years; odds ratio, 1.68 per 1 mmol/L LDL-C; odds ratio, 1.33 per 10 mm Hg SBP) in multivariable Mendelian randomization analyses.
"These findings support the importance of lifelong risk factor monitoring, and treatment should not be withheld in the elderly based on age alone," the authors write. "Greater emphasis is needed on the treatment of young individuals with elevated SBP and LDL-C, whose risk of CHD accumulates throughout life."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-21 08:15
Read more
- Poll Finds Most Americans Stressed Over Election, Future of Nation
- Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
- COVID-19 Pandemic-Linked Increase in Alcohol Use Persisting
- Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery
- ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
- Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions